Loss of imprinting and promoter usage of the IGF2 in laryngeal squamous cell carcinoma

Cancer Letters

Volumn 238, Issue 2, 2006, Pages 224-229

  Grbesa, Ivana ^a   Ivkic, Mirko ^b   Pegan, Boris ^b   Gall Troselj, Koraljka ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

IGF2; Imprinting; Laryngeal squamous cell carcinoma; Promoter usage

Indexed keywords

SOMATOMEDIN B;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; GENETIC ANALYSIS; GENOME IMPRINTING; HETEROZYGOTE; HUMAN; HUMAN TISSUE; LARYNX CARCINOMA; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SQUAMOUS CELL CARCINOMA;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; GENOMIC IMPRINTING; HUMANS; INSULIN-LIKE GROWTH FACTOR II; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; PROMOTER REGIONS (GENETICS);

EID: 33744984145     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.07.003     Document Type: Article

References (24)

1. Yao X., Hu J.F., Daniels M., Shiran H., Zhou X., Yan H., Lu H., Zeng Z., Wang Q., Li T., and Hoffman A.R. A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinoma. J. Clin. Invest. 111 (2003) 265-273
2. Zhang L., Zhou W., Velculescu V.E., Kern S.E., Hruban R.H., Hamilton S.R., Vogelstein B., and Kinzler K.W. Gene expression profiles in normal and cancer cells. Science 276 (1997) 1268-1272
3. Vu T.H., and Hoffman A.R. Promoter-specific imprinting of the human insulin-like growth factor-II gene. Nature 371 (1994) 714-717
4. Ekström T.J., Cui H., Li X., and Ohlsson R. Promoter-specific IGF2 imprinting status and its plasticity during human liver development. Development 121 (1995) 309-316
5. Sambrook J., Fritsch E.F., and Maniatis T. Extraction with phenol:chloroform. In: Ford N., Nolan C., and Ferguson M. (Eds). Molecular Cloning: Laboratory Manual (1989), Cold Spring Harbor Laboratory Press, Cold Spring Harbor E.3-E.4
6. Mitchell L.G., Bodenteich A., and Merril C.R. Use of silver staining to detect nucleic acids. In: Harwood A.J. (Ed). Methods in Molecular Biology: Protocol for Gene Analysis (1994), Humana Press, Totowa 197-203
7. Roy R.N., Cecutti A., Gerulath A.H., Steinberg W.M., and Bhavnani B.R. Endometrial transcripts of human insulin-like growth factors arise by differential promoter usage. Mol. Cell. Endocrinol. 135 (1997) 11-19
8. Cui H., Horon I.L., Ohlsson R., Hamilton S.R., and Feinberg A.P. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat. Med. 4 (1998) 1276-1280
9. Cui H., Cruz-Correa M., Giardiello F.M., Hutcheon D.F., Kafonek D.R., Brandenburg S., Wu Y., He X., Powe N.R., and Feinberg A.P. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 299 (2003) 1753-1755
10. Vu T.H., Chuyen N.V., Li T., and Hoffman A.R. Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor. Cancer Res. 63 (2003) 1900-1905
11. Kim S.J., Park S.E., Lee C., Lee S.Y., Jo J.H., Kim J.M., and Oh Y.K. Alternations in promoter usage and expression levels of insulin-like growth factor-II and H19 genes in cervical carcinoma exhibiting biallelic expression of IGF2. Biochim. Biophys. Acta 1586 (2002) 307-315
12. Mineo R., Fichera E., Liang S.J., and Fujita-Yamaguchi Y. Promoter usage for insulin like growth factor II in cancerous and benign human breast, prostate, and bladder tissues and confirmation of a 10th exon. Biochem. Biophys. Res. Commun. 268 (2000) 886-892
13. Pham N.V., Nguyen M.T., Hu J.F., Vu T.H., and Hoffman A.R. Dissociation of IGF2 and H19 imprinting in human brain. Brain Res. 810 (1998) 1-8
14. Zhan S., Shapiro D., Zhan S., Zhang L., Hirschfeld S., Elassal J., and Helman L.J. Concordant loss of imprinting of the human insulin-like growth factor II gene promoters in cancer. J. Biol. Chem. 270 (1995) 27983-27986
15. Vu T.H., and Hoffman A.R. Alternations in the promoter-specific imprinting of the human insulin like growth factor-II gene in Wilms' tumor. J. Biol. Chem. 271 (1996) 9014-9023
16. Anderson J., Gordon A., McManus A., Shipley J., and Pritchard-Jones K. Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma. Neoplasia 1 (1999) 340-348
17. Issa J.P., Vertino P.M., Boehm C.D., Newsham I.F., and Baylin S.B. Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis. Proc. Natl. Acad. Sci. USA 93 (1996) 11757-11762
18. Morison I.M., Eccles M.R., and Reeve A.E. Imprinting of insulin-like growth factor 2 is modulated during hematopoiesis. Blood 96 (2000) 3023-3028
19. Taniguchi T., Sullivan M.J., Ogawa O., and Reeve A.E. Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor. Proc. Natl. Acad. Sci. USA 92 (1995) 2159-2163
20. Pedersen S.K., Christiansen J., Hansen T.O., Larsen M.R., and Nielsen F.C. Human insulin like growth factor-II leader 2 mediates internal initiation of translation. Biochem. J. 363 (2002) 37-44
21. Von Horn H., Ekström C., Ellis E., Olivecrona H., Einarsson C., Tally M., and Ekström T.J. GH is a regulator of IGF2 promoter-specific transcription in human liver. J. Endocrinol. 172 (2002) 457-465
22. Li X., Adam G., Cui H., Sandstedt B., Ohlsson R., and Ekström T.J. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting. Oncogene 11 (1995) 221-229
23. Wang W.H., Duan J.X., Vu T.H., and Hoffman A.R. Increased expression of the insulin like growth factor-II gene in Wilms' tumor is not dependent on loss of genomic imprinting or loss of heterozygosity. J. Biol. Chem. 271 (1996) 27863-27870
24. Eriksson T., Frisk T., Gray S.G., von Schweinitz D., Pietsch T., Larsson C., Sandstedt B., and Ekström T.J. Methylation changes in the human IGF2 P3 promoter, parallel IGF2 expression in primary tumor, established cell line, and xenograft of a human hepatoblastoma. Exp. Cell Res. 270 (2001) 88-95